$3.67
+0.08 (+2.23%)
Open$3.57
Previous Close$3.59
Day High$3.74
Day Low$3.53
52W High$16.34
52W Low$2.94
Volume—
Avg Volume128.5K
Market Cap130.14M
P/E Ratio—
EPS$-6.12
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+375.5% upside
Current
$3.67
$3.67
Target
$17.45
$17.45
$10.78
$17.45 avg
$19.60
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.80M | 4.99M | 51.72M |
| Net Income | -170,060,954 | -159,117,224 | -16,237,176 |
| Profit Margin | -3,544.0% | -3,366.8% | -31.4% |
| EBITDA | -34,346,220 | -33,921,310 | -19,844,642 |
| Free Cash Flow | — | — | -12,228,215 |
| Rev Growth | -3.8% | -3.8% | -2.8% |
| Debt/Equity | — | — | 1.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |